| scholarly article | Q13442814 |
| P2093 | author name string | H Endoh | |
| S Kato | |||
| H Fuse | |||
| J Yanagisawa | |||
| K Takeyama | |||
| S Kitanaka | |||
| A Murayama | |||
| M Suzawa | |||
| Y Masuhiro | |||
| P2860 | cites work | Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells | Q24314557 |
| The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways | Q24320338 | ||
| Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor | Q24323091 | ||
| Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors | Q24324051 | ||
| Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 | Q24324556 | ||
| Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor | Q24532913 | ||
| TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors | Q24562254 | ||
| Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1 | Q24563324 | ||
| GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors | Q24600501 | ||
| A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system | Q24601592 | ||
| Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 | ||
| Sequence and characterization of a coactivator for the steroid hormone receptor superfamily | Q27860465 | ||
| A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors | Q27860552 | ||
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| SH2 domains recognize specific phosphopeptide sequences | Q27860748 | ||
| The transcriptional coactivators p300 and CBP are histone acetyltransferases | Q27860843 | ||
| A signature motif in transcriptional co-activators mediates binding to nuclear receptors | Q27860938 | ||
| AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer | Q28245902 | ||
| 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis | Q28248764 | ||
| Steroid receptor coactivator-1 is a histone acetyltransferase | Q28248899 | ||
| Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription | Q28254487 | ||
| A Novel Vitamin D3Analog, 22-Oxa-1, 25- Dihydroxyvitamin D3, Inhibits the Growth of Human Breast Cancerin Vitroandin Vivowithout Causing Hypercalcemia* | Q28327218 | ||
| Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning | Q28508915 | ||
| Correlation of two-hybrid affinity data with in vitro measurements | Q29615774 | ||
| Role of CBP/P300 in nuclear receptor signalling | Q29616443 | ||
| Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase | Q29617567 | ||
| Steroid hormone receptors: many actors in search of a plot | Q29618397 | ||
| Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene | Q34460757 | ||
| Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. | Q36555582 | ||
| Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity | Q37638476 | ||
| Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathway | Q38356179 | ||
| Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability | Q38483768 | ||
| Molecular biology of the vitamin D hormone | Q39311745 | ||
| Structure-function relationships in the vitamin D endocrine system | Q40545127 | ||
| Vitamin D-regulated gene expression. | Q40855785 | ||
| Vitamin D, calcium, and epidermal differentiation | Q40906153 | ||
| Transcription properties of a cell type-specific TATA-binding protein, TRF. | Q41086793 | ||
| TAFs and TFIIA mediate differential utilization of the tandem Adh promoters | Q41308314 | ||
| Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3. | Q41344708 | ||
| TAFs: guilt by association? | Q41444675 | ||
| The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. | Q41731155 | ||
| Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription | Q42439013 | ||
| Regulatory activities of 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism | Q44333378 | ||
| ERC-55, a binding protein for the papilloma virus E6 oncoprotein, specifically interacts with vitamin D receptor among nuclear receptors | Q45762820 | ||
| Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors | Q46828991 | ||
| Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. | Q52526986 | ||
| A canonical structure for the ligand-binding domain of nuclear receptors | Q61818643 | ||
| The effect of active vitamin D3 analogs and dexamethasone on the expression of osteocalcin gene in rat tibiae in vivo | Q67973794 | ||
| Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues | Q69782785 | ||
| 26,26,26,27,27,27-Hexafluoro-1,25-dihydroxyvitamin D3: A highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3 | Q70195321 | ||
| 25-hydroxy-26, 26,26,27,27,27-hexafluorovitamin D3: biological activity in the rat | Q70535718 | ||
| Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression | Q72403594 | ||
| Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1 | Q74083189 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| vitamin D | Q175621 | ||
| P304 | page(s) | 1049-1055 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog | |
| P478 | volume | 19 |
| Q31943152 | (23S)- and (23R)-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1alpha,25-dihydroxyvitamin D(3). |
| Q28477606 | 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor |
| Q37558961 | A new role for vitamin D receptor activation in chronic kidney disease |
| Q24545696 | A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA |
| Q35117084 | An update on the therapeutic potential of vitamin D analogues |
| Q73133819 | Analysis of the molecular mechanism for the antagonistic action of a novel 1alpha,25-dihydroxyvitamin D(3) analogue toward vitamin D receptor function |
| Q34566267 | Antiproliferative action of vitamin D. |
| Q43248702 | CDP/cut is an osteoblastic coactivator of the vitamin D receptor (VDR). |
| Q31943130 | Central role of VDR conformations for understanding selective actions of vitamin D(3) analogues |
| Q44081405 | Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells |
| Q34669513 | Coregulator proteins and corticosteroid action in the brain. |
| Q60628195 | Corticosteroid receptors and HPA-axis regulation |
| Q44539037 | Design and synthesis of potent vitamin D receptor antagonists with A-ring modifications: remarkable effects of 2alpha-methyl introduction on antagonistic activity |
| Q47794526 | Detecting ligands and dissecting nuclear receptor-signaling pathways using recombinant strains of the yeast Saccharomyces cerevisiae |
| Q28145136 | Differential mechanisms of nuclear receptor regulation by receptor-associated coactivator 3 |
| Q46977091 | Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia |
| Q34469351 | Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer. |
| Q41375077 | Drosophila TRAP230/240 are essential coactivators for Atonal in retinal neurogenesis |
| Q36712981 | Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease |
| Q28198990 | Endogenous bile acids are ligands for the nuclear receptor FXR/BAR |
| Q53425803 | Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype. |
| Q42521900 | Expression and regulation of nuclear receptor coactivators in glucocorticoid action |
| Q34132690 | From ligand to response: generating diversity in nuclear receptor coregulator function. |
| Q33804590 | Genetic mutation in the human 25-hydroxyvitamin D3 1alpha-hydroxylase gene causes vitamin D-dependent rickets type I. |
| Q31943055 | History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2beta-(3-hydroxypropoxy)calcitriol (ED-71). |
| Q46633685 | Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target |
| Q34435158 | Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. |
| Q43584307 | Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements |
| Q40681053 | Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the peroxisome proliferator-activated receptor gamma. |
| Q43653150 | Ligand recognition by the vitamin D receptor |
| Q28143758 | Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators |
| Q39674733 | Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex |
| Q39289974 | Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3. |
| Q36947028 | Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease |
| Q43825196 | Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium |
| Q35802815 | Pharmacology of nuclear receptor-coregulator recognition. |
| Q24554468 | Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha |
| Q55920649 | RETRACTED: Nuclear Receptor Function Requires a TFTC-Type Histone Acetyl Transferase Complex |
| Q40605771 | Remarkable effect of 2[small alpha]-modification on the VDR antagonistic activity of 1small alpha-hydroxyvitamin D3-26,23-lactones |
| Q42487253 | Repressive domain of unliganded human estrogen receptor alpha associates with Hsc70. |
| Q40503211 | Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative |
| Q44188850 | Synthesis and testing of 2alpha-modified 1alpha,25-dihydroxyvitamin D(3) analogues with a double side chain: marked cell differentiation activity |
| Q39562796 | Synthesis of C-2 substituted vitamin D derivatives having ringed side chains and their biological evaluation, especially biological effect on bone by modification at the C-2 position |
| Q22253199 | The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand |
| Q37281181 | The enhanced hypercalcemic response to 20-epi-1,25-dihydroxyvitamin D3 results from a selective and prolonged induction of intestinal calcium-regulating genes |
| Q37481349 | Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands |
| Q40413870 | Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching |
| Q40692111 | Two novel metabolic pathways of 22-oxacalcitriol (OCT). C-25 dehydration and C-3 epimerization and biological activities of novel OCT metabolites |
| Q36099016 | Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism |
| Q43991826 | Vitamin D analogue-specific recruitment of vitamin D receptor coactivators |
| Q45373448 | Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease |
| Q35094837 | Vitamin D metabolism, mechanism of action, and clinical applications |
| Q36947025 | Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies |
| Q46704636 | Vitamin D regulation of cathelicidin in the skin: toward a renaissance of vitamin D in dermatology? |
| Q31943140 | Vitamin D(3) analogs (MC 1288, KH 1060, EB 1089, GS 1558, and CB 1093): studies on their mechanism of action. |
| Q52568905 | Yeast two-hybrid detection systems that are highly sensitive to a certain kind of endocrine disruptors. |
| Q57849061 | p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor α and β by Interacting Directly with the N-terminal A/B Domains |
Search more.